Insulin rapidly stimulates tyrosine kinase activity of its receptor resulting in phosphorylation of its cytosolic substrate insulin receptor substrate 1 (IRS-l), which in turn associates with and activates the enzyme phosphatidylinositol 3-kinase (PI 3-kinase). In the present study we have examined these three initial steps in insulin action during the differentiation of 3T3-F442A adipocytes and after treatment with dexamethasone or insulin. The differentiation of 3T3-F442A cells was characterized by a 13-fold increase in insulin receptor protein, a O-fold increase in IRS-l, and a lo-and 4.5-fold increase in their insulin-stimulated phosphorylation, respectively. The mRNA expression of these two proteins showed a similar 8-fold increase during differentiation.
Insulin rapidly stimulates tyrosine kinase activity of its receptor resulting in phosphorylation of its cytosolic substrate insulin receptor substrate 1 (IRS-l), which in turn associates with and activates the enzyme phosphatidylinositol 3-kinase . In the present study we have examined these three initial steps in insulin action during the differentiation of 3T3-F442A adipocytes and after treatment with dexamethasone or insulin. The differentiation of 3T3-F442A cells was characterized by a 13-fold increase in insulin receptor protein, a O-fold increase in IRS-l, and a lo-and 4.5-fold increase in their insulin-stimulated phosphorylation, respectively. The mRNA expression of these two proteins showed a similar 8-fold increase during differentiation.
In addition there was a 3.5 fold increase in PI 3-kinase protein [85 kilodalton (kDa) subunit] and a 16-fold increase in IRS-l-associated PI 3-kinase activity between day 0 and day 8 of differentiation. Dexamethasone (1 ELM) treatment of differentiated cells induced a further 48% (P e 0.05) increase in insulin receptor level, but the autophosphorylation of the receptor was decreased by 31 + 1% (P c 0.02). At the same time there was a decrease by 56 + 4% (P e 0.005) in IRS-1 protein and by 31 + 1% (P c 0.001) in IRS-1 phosphorylation.
The expression of insulin receptor mRNA was unchanged, but the expression of IRS-1 mRNA was decreased by -75% after dexamethasone.
By contrast, dexamethasone induced a 69% increase in the level of PI 3-kinase as determined by immunoblotting. The combined effect of decreased IRS-1 phosphorylation and increased PI 3-kinase protein was a minimal change oeee-8809/94/0545-0557$03 00/o Molecular Endocrmolcqy Copynght 0 1994 by The Endocrine Society (15% decrease) in the association/activation between IRS-1 and PI 3-kinase.
Chronic treatment with 100 nM insulin induced a time-and dose-dependent decrease in insulin receptor and IRS-1 protein levels reaching a nadir of 34 + 5% (P < 0.005) and 39 f 5% (P < 0.01) of control levels after 24 h, respectively. There was an even more marked decrease in the phosphorylation level of these proteins.
Chronic insulin treatment also produced a 30% decrease in PI 3-kinase protein levels and a -50% decrease in the association/ activation between IRS-l/PI 3-kinase. The expression of insulin receptor and IRS-1 mRNA was unchanged during chronic insulin treatment. Thus three of the early steps in insulin action may have an important role in the process of adipocyte differentiation and represent points of regulation in hormone-induced insulin resistance in 3T3-F442A adipocytes. (Molecular Endocrinology 8: 545-557, 1994) INTRODUCTION Certain clones of 3T3 cells (3T3-Ll and 3T3-F442A) can differentiate into adipocytes with high frequency in cell culture in a process closely resembling the differentiation of adipocytes in early life (1). The development of the fatty phenotype is accompanied by a marked increase in triglyceride content, as well as increased activity of lipogenic and lipolytic enzymes (2). Sensitivity to hormones known to affect adipocyte metabolism develops concomitantly with the expression of the fatty phenotype. With differentiation, the cells show an increase in insulin binding (3) (4) (5) and in insulin receptor mRNA (6, 7) and a parallel increase in insulin-stimulated glucose uptake and oxidation (5, 7). These character-MOL ENDO. 1994 546 Vol 8 No. 5 istics make the 3T3-F442A cells an attractive model for studies of insulin action at the postreceptor level. Over the past decade, there has been a dramatic increase in our understanding of the early postreceptor events in insulin action. After insulin binding to the (Ysubunit of its receptor, there is an activation of the kinase in the p-subunit (8, 9) . This catalyzes the intramolecular autophosphorylation of specific tyrosine residues of the G-subunit, further enhancing the tyrosine kinase of the receptor toward other protein substrates (10). In most cells, this leads to the subsequent tyrosyl phosphorylation of a cytoplasmic protein with an apparent mol wt between 160 and 185 K, called insulin receptor substrate 1 (IRS-l) (1 O-l 2). Considerable evidence indicates that insulin receptor tyrosine kinase and associated IRS-1 phosphorylation are essential for many, if not all, of the biological effects of insulin (8, (13) (14) (15) . In studies performed using in vivo models of insulin action, cells in culture, as well as in vitro reconstitution systems, phosphorylated IRS-1 associates with the lipid metabolizing enzyme phosphatidylinositol 3-kinase (PI 3-kinase), thus activating the enzyme (16, 17) . Thus, the insulin receptor, IRS-l, and PI 3-kinase represent three of the earliest steps in insulin action. In addition, recent studies have indicated that in states of insulin resistance, alterations of these steps may contribute to the altered insulin action profile (18) (19) (20) (21) (22) .
In the present study we have examined the phosphorylation state of the insulin receptor and IRS-1 and PI 3-kinase activity after insulin stimulation in vivo, as well as the levels of these three proteins and their mRNAs during differentiation of 3T3-F442A adipocytes. We also examined the regulation of these early steps of insulin action in mature 3T3-F442A cells by chronic treatment with two hormones that can induce insulin resistance, i.e. insulin or dexamethasone (18) (19) (20) (21) (22) .
RESULTS

Expression of Insulin Receptor and IRS-1 during the Differentiation of 3T3-F442A Adipocytes
Differentiation of 3T3-F442A cells was enhanced by the addition of 5 pg/ml insulin for the first 6 days followed by culture for 48 h in Dulbecco's minimal essential medium (DMEM) supplemented with 10% fetal calf serum without insulin. By the end of this period 90-95% of the cells acquired the characteristic adipocyte morphology accumulating a large number of lipid droplets. As previously reported (4, 5) differentiation is characterized by a marked increase in insulin binding, which increased 13-fold between day 0 and day 8 (Fig.  1A ). This increase in insulin binding is primarily accounted for by an increase in receptor number with no significant change in receptor affinity (4,5). The increase in receptor level was further confirmed by immunoblotting with a C terminus antibody against insulin receptor (Fig. 2C) . insulin-stimulated receptor tyrosine phosphorylation also increased IO-fold as cells progressed and receptor tyrosine phosphorylation levels were determined by scanning densitometry of autoradiograms of antiphosphotyrosine antibody. The results represent the mean -c SEM of four separate experiments. B, IRS-1 protein and phosphorylation levels during differentiation of 3T3-F442A cells. Scanning densitometry of autoradiograms of anti-IRS-l and anti-phosphotyrosine antibody were used to determine IRS-1 protein and phosphorylation levels. The results represent the mean f SEM of four separate experiments and are expressed as percent of control (day 0). C, Effect of differentiation on expression of insulin receptor and IRS-1 mRNA in 3T3-F442A cells. One microgram of total RNA prepared from cells in different days of differentiation was reverse transcribed into cDNA in the presence of the three 3'-primers (1 pmol of each primer/reaction). One twentieth of total cDNA was subjected to PCR using endlabeled primers for insulin receptor (IR), . Negative and positive controls were used as described in Methods (data not shown).
from nondifferentiated to completely differentiated 3T3-F442A adipocytes (Figs. 1 A and 2A) .
In parallel there was a g-fold increase in IRS-1 protein levels from preadipocytes to differentiated adipocytes (Figs. 1B and 2B) and a 4.5-fold increase in insulinstimulated IRS-1 phosphorylation (Figs. 1B and 2A ). The lesser increase in IRS-1 phosphorylation, as com- pared to IRS-l protein and insulin receptor phosphoryiation, suggested the possibility of an increase in cytosolic protein tyrosine phosphatase (PTPase) which might act preferentially on IRS-l VS. insulin receptor. Indeed, there was a 50% increase in cytosolic PTPase activity from day 0 to day 8 differentiation (data not shown), which may contribute to the differential increase in tyrosine phosphorylation of these proteins. To determine whether the changes in insulin receptor and IRS-l protein levels were regulated at the mRNA level, we determined the expression of mRNA in these two proteins using quantitative polymerase chain reaction (PCR). During differentiation there was a progressive and gradual increase in mRNA level of both insulin receptor and IRS-1 reaching an 8-fold increase by day 8 when 90-95% of the cells have the adipocyte morphology (Fig. 1C) . These results are in agreement with previous reports on the expression of insulin receptor mRNA during the differentiation of 3T3-Ll preadipocytes (6, 7) and suggest that the increase in gene transcription of insulin receptor and IRS-1 play a key role in the increased expression of these proteins during differentiation.
&Microglobulin, which was used as a control, also increased during differentiation, but to a much lesser extent (data not shown).
Effect of Differentiation
on PI 3-Kinase in 3T3-F442A Cells
To determine the impact of changes in IRS-l expression and phosphorylation on further downstream effects, PI 3-kinase activity was measured in nondifferentiated and completely differentiated cells (Fig. 38) . A very low level of basal PI 3-kinase activity was present in anti-IRS-l immunoprecipitates from 3T3-F442A fibroblasts, which rapidly increased about 6-fold following acute insulin stimulation (Fig. 3B) . After differentiation into adipocytes, the basal PI 3-kinase activity in anti-IRS-l immunoprecipitates was 10 times higher than in 3T3-F442A fibroblasts, and insulin stimulation produced a further 8-fold increase over basal levels. In other words, there was a 16-fold increase in IRS-l -associated PI 3-kinase activity after acute insulin stimulation in 3T3-F442A adipocytes (day 8) as compared to fibroblasts (day 0). Based on immunoblotting the total cell extracts with an antibody to the 85 kDa of PI 3-kinase, the levels of this enzyme protein increased only -3-fold during differentiation of the 3T3-F442A cells (Fig. 3A) . Thus, the increase in the amount of the enzyme can account for only a part of the increase in PI 3-kinase activity associated with IRS-l after differentiation and suggests that other regulatory events or factors might play a role in the control of this enzyme.
Effect of Dexamethasone
on Insulin Receptor and IRS-1 Phosphorylation in 3T3-F442A Adipocytes
When fully differentiated 3T3-F442A adipocytes were treated with dexamethasone (1 PM) for 6 h there was a 42 + 16% increase in insulin receptor levels as detected by immunoblotting with antireceptor antibody (P < 0.05). After 24 h of dexamethasone, insulin receptor levels increased only slightly to 48 + 21% (P < 0.05) (Figs. 4D and 5A) . By contrast, insulin stimulation of insulin receptor autophosphorylation as detected by immunoblotting with antiphosphotyrosine antibodies decreased in 3T3-F442A with dexamethasone reaching a nadir of 69 f 1% of control levels after 24 h of treatment (P < 0.02) (Figs. 4A and 58) . When the change in phosphorylation was normalized for the increase in receptor content, there was a -50% decrease in receptor autophosphorylation per receptor, after 12 h and 24 h of dexamethasone treatment. During the same time course, there was a progressive and significant decrease in IRS-l protein levels, reaching 44 +-4% of control levels (P < 0.005) after 24 h (Figs. 4B and 5A). The level of insulin-stimulated tyrosine phosphorylation of IRS-l showed a parallel decrease reaching 73 f 1% (P < 0.01) and 69 + 1% (P < 0.01) of control values at 12 h and 24 h of dexamethasone treatment, respectively (Figs. 4A and 5B) . However when the latter data were corrected for the level of IRS-1, there was actually a slight, although not significant increase in the apparent stoichiometry of IRS-l phosphorylation.
To test the hypothesis that the changes in insulin receptor (increase) and IRS-l (decrease) induced by dexamethasone might be regulated at the mRNA levels, insulin receptor and IRS-l mRNA were estimated by quantitative PCR in 3T3-F442A adipocytes before and after dexamethasone
(1 PM) treatment. Insulin receptor mRNA did not change during glucocorticoid treatment ( Cells were treated with or without 1000 nM dexamethasone for 1, 6, 12, and 24 h, and were stimulated with normal saline (lane 1) or 1 O-' M insulin (lanes 2, 3, 4, 5, and 6) for 1 min and then extracted and homogenized in extraction buffer A at 4 C as described in Methods. After centrifugation, aliquots with the same amount of protein were resolved on 6% SDSpolyacrylamide gel, transferred to nitrocellulose, and detected with antiphosphotyrosine antibody (A), anti-IRS-l antibody (B),antiinsulin receptor antibody (C), or anti-PI 3-kinase antibody(D), and ['Z51]protein A and subjected to autoradiography. cantly decreased to 67 f 1% (P < O.Ol), 22 f 13% (P c O.Ol), and 24 + 13% (P < 0.01) of control ceils after 1 h, 6 h, and 24 h of dexamethasone treatment, respectively (Fig. 6 , B and D). @Macroglobulin mRNA, used as control, did not change during dexamethasone treatment (Fig. 6C ). These results suggest that the decrease in IRS-1 protein level is secondary to a decrease in IRS-1 mRNA. In on-going studies we have found that this is due to a change in IRS-1 mRNA halflife rather than transcriptional regulation of the gene (E. Araki and C. R. Kahn, submitted for publication).
To determine whether the reductions in insulin receptor and IRS-1 phosphorylation were accompanied by a reduction in the association/activation between IRS-1 / PI 3-kinase, 3T3-F442A adipocytes were treated with dexamethasone (1 PM) for 24 h, stimulated with insulin for 1 min, and then extracted as described in Materials and Methods for PI 3-kinase activity. A low level of basal PI 3-kinase activity was found in anti-IRS-l immunoprecipitates from control cells and cells treated with dexamethasone.
After insulin stimulation, there was 1 O-fold increase in IRS-l -associated PI 3-kinase activity in control cells and an 8.5-fold increase in cells treated with dexamethasone ( Fig. 7) . This modest 15% reduction in IRS-l-associated PI 3-kinase activity is much less than the reduction in IRS-1 protein and/or phosphorylation levels. lmmunoblotting the cell extracts with an antibody to the 85-kDa subunit of PI 3-kinase revealed a progressive increase in PI 3-kinase protein levels following dexamethasone treatment reaching a maximum of 169 + 22% of control levels after 24 h (Fig. 8A) . Thus, an increase in PI 3-kinase enzyme level may prevent a major decline in IRS-l-associated PI 3-kinase activity as might have been expected by the decrease in IRS-1 phosphorylation levels. To evaluate the effect of chronic insulin exposure on insulin receptor and IRS-1 phosphorylation, differentiated 3T3-F442A adipocytes cells were treated with 100 nM insulin for periods up to 24 h. Between 1 and 24 h, there was a progressive decrease in insulin receptor level, as detected by immunoblotting with receptor antibodies, reaching a nadir of 34 f 5% of control levels (P c 0.005) after 24 h of insulin treatment (Figs. 9C and 1 OA). Chronic exposure of differentiated 3T3-F442A cells to 100 nM insulin also resulted in a decrease in IRS-1 levels reaching 39 f 5% (P < 0.01) of basal levels at 24 h (Figs. 9B and 1 OA). In addition, following acute insulin stimulation and up to 6 h of insulin treatment, there was a decrease in mobility reflecting an increase in the degree of phosphorylation of IRS-l resulting from insulin stimulation. This was confirmed by direct immunoblotting with antiphosphotyrosine antibodies (Fig. 9A) . Thus, in the basal state there was a constitutively phosphorylated protein, in 3T3-F442A adipocytes, with molecular mass of 120 kilodaltons (kDa). After insulin stimulation for 1 min the insulin receptor psubunit (95 kDa) and IRS-1 (broad band between 165-185 kDa) appeared and became prominently phosphorylated in the phosphotyrosine immunoblotting. Following chronic insulin treatment there was an increase in basal insulin receptor and IRS-1 phosphorylation. The increase in basal insulin receptor and IRS-1 phosphorylation were maximal at 1 h, decreasing progressively until 24 h. Acute insulin stimulation did not change the pattern of the chronic insulin effect on phosphorylation of both proteins during the time course of 24 h. By comparison with control cells, acute insulin-induced insulin receptor phosphorylation was decreased to 68 f 1% (P < 0.05) 16 f 2% (P c 0.005) and 16 f 4% (P < 0.005) after 6 h, 12 h, and 24 h of chronic insulin treatment, respectively, with similar changes in IRS-1 phosphorylation (Figs. 9A and 1OB). The reduction in insulin receptor phosphorylation was greater than the decrease in insulin receptor protein levels, suggesting a modest decrease in the stoichiometry of insulin receptor autophosphorylation during chronic insulin treatment. The change in IRS-1 phosphorylation was parallel to the change in IRS-1 protein levels during the first 6 h of insulin treatment. The decrease in IRS-1 phosphorylation levels became more marked after 12 h (15 f 2%, P < 0.005) and 24 h (9 f l%, P c 0. in 3T3-F442A adipooytes. The level of insulin receptor detected by immunoblotting with antiinsulin receptor antibody did not change after treatment with 0.01 nM insulin, but decreased significantly with 1 nM and reached 14 f 9% (P c 0.01) of control level with 100 nM insulin (Fig. 12A) . At the same time the levels of IRS-1 protein did not change with 0.01 nM and 1 nM insulin, and were reduced to 43 + 8% of control levels after 24 h of 100 nM insulin (P < 0.02) (Figs. 11 B and  12A ).
On phosphotyrosine immunoblots there was a progressive decrease in acute insulin-induced insulin receptor phosphorylation levels reaching a nadir of 29 + 4% (P < 0.01) after 24 h of exposure of the cells to 100 nM insulin (Figs. 11 A and 12A) . At all concentrations of chronic insulin there was no difference between insulin receptor protein levels and insulin receptor phosphorylation levels suggesting that the autophosphorylation of insulin receptor did not change on a per receptor basis. The decrease observed with IRS-l phosphorylation was more marked after 0.01 nM insulin for 24 h, but very similar, and paralleled the decrease in receptor phosphorylation with the two highest doses (Figs. 11 A and 128) ation level at all concentrations of insulin was also more marked than the decrease in IRS-1 protein levels suggesting a reduction in IRS-1 phosphorylation per molecule and a reduction in insulin receptor tyrosine kinase activity toward its endogenous substrate IRS-l. No consistent change in insulin receptor and IRS-1 mRNA levels were observed in the time course of insulin treatment (data not shown), indicating that the decrease in the level of these two proteins induced by insulin is not regulated at mRNA levels. and extracted, and immunoprecipitates with antibodies to IRS-l were assayed in vitro for PI 3-kinase activity. A low level of basal PI 3-kinase activity was present in the anti-IRS-l immunoprecipitates of control 3T3-F442A adipocytes cells before insulin stimulation, and after 1 min of insulin stimulation there was a lo-fold increase in IRS-l-associated PI 3-kinase activity (Fig.  7) . Chronic insulin (100 nM) treatment for 24 h produced a sustained increase in basal IRS-l-associated PI 3-kinase activity of -g-fold (Fig. 7) . During the period of chronic insulin treatment, IRS-l -associated PI 3-kinase activity did not change over basal with further acute insulin stimulation. Indeed, by comparison with acute insulin stimulated in control cells there was a 53% decrease after 24 h of 100 nM insulin (Fig. 7) . This decrease in PI 3-kinase activity in immunoprecipitates of IRS-l was accompanied by a reduction in PI 3-kinase protein levels of 27 f 11% (P c 0.05) and 38 f 8% (P < 0.02) at 6 h and 24 h, respectively, as determined by immunoblotting with antibodies to the 85 kDa subunit of PI 3-kinase (Fig. 88) . The cells were chronically treated with or without 100 nM insulin for 1, 6, 12, and 24 h (0) and were acutely stimulated with normal saline (lanes 1, 3, 5, 7, and 9) or 10e7 M insulin (lanes 2, 4, 6, 8, and 10) for 1 min, then extracted and homogenized in extraction buffer A at 4 C as described in Methods.
After centrifugation, aliquots with the same amount of protein were resolved on 6% SDS-polyacrylamide gel, transferred to nitrocellulose, and detected with antiphosphotyrosine antibody (A), anti-IRS-l antibody (B), antiinsulin receptor antibody (C) and [1z51]protein A and subjected to autoradiography.
DISCUSSION
Although the exact molecular events linking the insulin receptor tyrosine kinase to its final cellular actions remain poorly understood, several of the early steps in the insulin action cascade have been defined at a molecular level. Following insulin binding, the activated insulin receptor kinase catalyzes tyrosine phosphorylation of a cytoplasmic protein of relative molecular mass between 165 and 185 kDa termed IRS-1 (10-12). IRS-1 is a substrate of insulin, insulin-like growth factor-l, and interleukin-4 receptors (1 O-l 2, 23, 24) and following its phosphorylation can associate with proteins containing Src homology 2 (SH2) domains through specific tyrosyl phosphorylation sites (16, (25) (26) (27) (28) . This association leads to an activation of the enzyme PI 3-kinase (16, 17) . In the present study we have evaluated the regulation of expression and function of the proteins involved in these early steps in insulin action during the differentiation of 3T3-F442A cells, as well as the effect of chronic treatment with dexamethasone or insulin on fully differentiated adipocytes. Our results show that the differentiation process is accompanied by a marked increase in insulin receptor and IRS-l levels. These results are in accordance with previous studies using 3T3-Ll cells (3) (4) (5) 29) . In addition, we find that the increase in insulin receptor and IRS-l levels parallel an increase in mRNA of these proteins suggesting that these changes are regulated at the transcriptional level. Interestingly, the increase in insulin-stimulated receptor and IRS-1 phosphorylation was less dramatic than the increase in the level of these two proteins. This may be due to an increase in the cytoplasmic phosphotyrosine phosphatase activity Cells were treated for 24 h with or without 0.01 nr.t, 1 nM, and 100 nM insulin for 24 h and then were acutely stimulated with lo-' M insulin for 1 min. The calls were extracted and homogenized in extraction buffer A at 4 C as described in Mefhods. After centrifugation, aliquots with the same amount of protein were resolved on 8% SDS-polyacrylamide gel, transferred to nitrocellulose, and detected with antiphosphotyrosine antibody (A), anti-IRS-l antibody (B) and ['251 ]protein A and subjected to autoradiography. which increases 50% as the cells differentiate from fibroblast to adipocyte. The differences between the increase in IRS-l protein and phosphorylation levels in 3T3-F442A adipocytes were more marked then those for the insulin receptor and suggest that IRS-1 may be more sensitive to dephosphorylation and/or subject to other regulatory influences. This is in accordance with the hypothesis of Mooney and Bordwell(30) who found that IRS-1 is dephosphorylated at a rate 4 times faster than the receptor in permeabilized adipocytes. During differentiation there is also an increase in PI 3-kinase levels and together with the increase in IRS-1 phosphorylation level this results in a large increase in association/activation between IRS-1 /PI 3-kinase. These results suggest that an increase at all three early postbinding steps in insulin action, i.e. insulin-induced insulin receptor and IRS-1 phosphorylation and activation of PI 3-kinase, play a role in the increased insulin responsiveness observed in the adipocyte phenotype.
We studied the effect of chronic treatment with insulin and dexamethasone on these early steps in insulin action in the fully differentiated adipocytes, since these two hormones are known to induce insulin resistance in a variety of physiological and pathological states (31, 32) . Chronic insulin treatment induced a time-and dosedependent decrease in insulin receptor and IRS-1 protein and phosphorylation level. Reduction of insulin receptor levels and kinase activity by chronic insulin treatment has previously been demonstrated in other intact cell systems (32) although this has not been uniformly observed (33). The decrease in IRS-1 levels paralleled the decrease in protein levels in the first 6 h, but after this there was a reduction in IRS-1 phosphorylation greater than could be accounted for by the decrease in IRS-1 protein. In this context, the changes in insulin receptor kinase in the same direction may have at least a permissive role, since the IRS-1 protein levels are not the only determinant of IRS-1 phosphorylation levels (19). Whether these regulatory defects induced by chronic hyperinsulinemia reflect alterations in receptor and IRS-1 serine phosphorylation or some other regulatory event is unknown. Recently, Rice ef a/. (29, 34) demonstrated that chronic exposure of 3T3-Ll adipocytes to insulin induced a decrease in IRS-1 protein levels in accordance with our results. We also showed similar results using insulin-sensitive rat hepatoma cells (M. J. A. Saad, F. Folk, and C. R. Kahn, submitted). The present study demonstrates that the reduction in insulin receptor and IRS-1 protein levels in 3T3-F442A adipocytes is not due to a decrease in the mRNA of these two proteins, suggesting that this desensitization process may be related to an increase in the rate of degradation of these proteins. Indeed, pulsechase labeling studies in 3T3-Ll adipocytes demonstrate that the rate of degradation of IRS-l protein is about 10 times faster in insulin-treated cells than in control cells (34).
Taken together, these results suggest that hyperinsulinemia by itself can induce alterations in three of the earliest steps in insulin action which may account, in part, for the phenomenon of insulin-induced desensitization. Altered autophosphorylation of the insulin receptor and kinase activity of the receptor toward endogenous substrate, as indicated by the phosphorylation of IRS-1 and activation of PI 3-kinase, also appear to be important in the altered signal transduction observed in cultured cells expressing mutant insulin receptors. Indeed, direct evidence that this pathway is required for insulin action is most clearly derived from experiments in which kinase-deficient receptors are overexpressed in various cell types (35, 46) . In these cells, the absence of biological activity correlates specifically with the inability of the mutant receptor to stimulate the tyrosyl phosphorylation of IRS-1 and consequently PI 3-kinase. Thus, reduced insulin receptor and IRS-1 phosphorylation and decreased PI 3-kinase activity may have an important role in reduced insulin action induced by chronic insulin treatment.
Chronic dexamethasone treatment induces a slight increase in insulin receptor levels in 3T3-F442A adipocytes. A similar increase is observed in Fao cells (M. J. A. Saad, F. Folli, and C. R. Kahn, 1993; submitted) , as well as several other cell types (36, 37) . This effect of dexamethasone occurs with no change in the level of insulin receptor mRNA, suggesting that a decrease in receptor degradation may account for the increase in receptor protein levels. Despite the increase in receptor protein, insulin-induced receptor autophosphorylation is decreased after dexamethasone treatment. The mechanisms for the decrease is unclear but might involve, for example, increased tyrosine phosphatase activity or increased serine-threonine phosphorylation of the receptor.
IRS-1 protein levels were decreased after dexamethasone treatment in accordance with previous data (29) and could be accounted for by a decrease in the level of mRNA of IRS-l. In parallel there is a decrease in IRS-1 phosphorylation, reflecting the decrease in protein levels as well as a decrease in the stoichiometry of phosphorylation level. Recently we demonstrated an opposite effect of dexamethasone on IRS-1 protein levels and phosphorylation in another cell line, the Fao hepatoma cell, i.e. both IRS-1 protein and phosphoryl- MOL ENDO. 1994 Vol 8 No. 5 554 ation increased after dexamethasone treatment. This confirms our previous data in animal tissues that IRS-1 expression has a tissue-specific regulation (18, 19) . Chronic corticosteroid treatment caused a mild and nonsignificant decrease in IRS-1 -associated PI 3-kinase activity. This phenomenon is in contrast to the decrease in IRS-1 protein and phosphorylation level and is due, at least in part, to an increase in the levels of PI 3-kinase protein. The increase in insulin-induced activation of PI 3-kinase activity during the differentiation process in these cells, as well as its differential regulation by insulin and dexamethasone in the differentiated state, parallels the changes observed in insulin-stimulated glucose transport (5, 38). In viva data seem to corroborate these findings. Glucose transport, as well as IRS-1 phosphorylation and PI 3-kinase activation after insulin stimulation, are severely impaired in hyperinsulinemic ob/ob and goldthioglucose obese mice (18, 20, 21, 39) . Furthermore, a specific inhibitor of PI 3-kinase (R. Cheatham, C. Vlahos, and C. R. Kahn, manuscript in preparation)
is able to selectively and efficiently inhibit glucose transport in these cells, without affecting other postreceptor insulin signaling pathways such as the microtubule-associated protein kinase. Thus, it is reasonable to speculate that the IRSl/PI 3-kinase pathway may be linked to activation of glucose transport and this cell type may help us to elucidate the regulatory mechanisms involved in this process.
It has been recently shown that specific phosphorylation sequences in the IRS-1 molecule are involved in the interaction with specific SH2 domains containing proteins. More specifically, phosphorylated YVNI and YIDL motifs bind GRB-2 and SHPTP-2, respectively (28) whereas phosphorylated YMXM or YXXM motifs bind PI 3-kinase (16). GRB-2 is the mammalian homolog of the Caenorhabditis elegans protein sem-5, a critical component in the signal transduction pathway that links receptor tyrosine kinases to ras activation (27, 28, 40) . SHPTP2/syp appears to be the mammalian homologue of the Drosophila gene corkscrew (csw) (41) which, in combination with the polehole gene product, belong to a terminal transduction pathway of the signals generated by torso, a receptor protein tyrosine kinase (42). Thus IRS-l appears to be a multisite docking protein, capable of activating or inhibiting different signal generating pathways. Based on this and other studies, it seems likely that the final metabolic or growth-promoting effects of insulin may be dictated by tissue-specific expression and regulation of IRS-1 and interacting proteins, as well as other components of the insulin signaling pathway. Changes in the stoichiometry of phosphorylation could be associated with changes in the sites phosphorylated and thus serve as a point for divergence of insulin resistance as well as insulin signaling.
In conclusion, during differentiation of 3T3-F442A fibroblast to adipocytes there is a marked increase in insulin receptor, IRS-1 protein, phosphorylation and PI 3-kinase levels and in the association/activation between IRS-l/PI 3-kinase. Chronic insulin treatment induces a decrease in insulin receptor and IRS-1 level and phosphorylation and also in the association/activation of IRS-l with PI 3-kinase. Chronic dexamethasone treatment induces an increase in insulin receptor and PI 3-kinase protein levels and a decrease in IRS-1 protein and phosphorylation levels. This results in a mild decrease in the association/activation of IRS-l/PI 3-kinase. Some of these effects are at the transcriptional level; others are not. This study underscores the importance of the complex regulation of different components of the insulin signal transduction pathway and further emphasize the concept of a tissue-, as well as hormone-specific, insulin resistance.
MATERIALS AND METHODS
Materials
Reagents for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were from BioRad Laboratories (Richmond, CA as previously described (11). Antirat-PI 3-kinase (~85 subunit) antiserum was from UBI (Lake Placid, NY). Antirnsulin receptor antibody was raised in rabbits using a synthetic peptide derived from the amino acid sequence (KKNGRILTLPRSNPS) corresponding to the C terminus of the @-subunit of the protein.
Cell Culture 3T3-F442A cells were grown in DMEM medium with 10% calf serum in 5% humidified COn atmosphere. Cells were differentiated in 10% CO? in DMEM medium supplemented with 10% fetal calf serum for 8 days. The differentiation was enhanced by the addition of 5 pg/ml insulin for the first 6 days. Cells were then withdrawn from Insulin and maintained in DMEM plus 10% fetal calf serum for 2 days. By the end of this period 90-95% of the cells acquired the characteristic adipocyte morphology.
The differentiated adipocytes (after day 8 and before day 11) were chronically treated with insulin or dexamethasone with a time course and dose-response as described in Results. Cells not treated with these hormones were used as controls. In all experiments the cells were also acutely stimulated without or with 100 nM porcine insulin for 1 min at 37 C. The cells were solubilized on ice with ice-cold buffer B containing 1% NP-40, 10% glycerol, aprotinin (2 rg/ ml), antipain (10 pg/ml), leupeptin (5 fig/ml), pepstatin (0.5 pg/ ml), benzamidine (1.5 mg/ml), and PMSF (34 pg/ml), and insoluble material was removed by centrifugation at 15,000 rpm in a 70Ti rotor (Beckman) for 50 min. IRS-l was immunoprecipitated from aliquots of the supernatant containing 1 mg protein with anti-IRS-l (crPep80, 0.3 pg/ml) or preimmune rabbit immunoglobulin G (0.3 Ilg/ml) followed by protein-Asepharose 6 MB. The immunoprecipitates were washed successively in PBS containing 1% NP-40 and 100 PM Na,VO, (3 times), 100 mM Tris (pH 7.5) containing 500 mM LiCI, and 100 HM Na3V04 (3 times), and 10 mM Tris (pH 7.5) containing 100 mM NaCI, 1 mM EDTA, and 100 PM Na3V04 (2 times). The pellets were resuspended in 50 @I 10 mrv Tris (pH 7.5) containing 100 mM NaCl and 1 mM EDTA. To each pellet was added 10 ~1 100 mM MgCI, and 10 ~1 phosphatidylinositol (2 pg/pl) sonicated in 10 mM Tris (pH 7. were reverse transcribed into cDNA using all three 3'-primers (1 pmol primer/reaction). After [32P] end-labeling of the PCR primers, 5% of the total cDNA was used as a template for the PCR reaction. The final PCR conditions were 10 pmol of each primer/reaction, denaturing at 94 C for 30 set, annealing at 57 C for 30 set, and extension at 72 C for 1 min. Based on pilot tests, linear amplification of IRS-l mRNA was achieved using 50 ng total RNA/reaction and 21-27 cycles (47). The final PCR products were separated on a 5% acrylamide gel in 0.5 x Tris/borate/ EDTA buffer. Gels were dried and subjected to autoradiography, and the radioactivity in the bands was determined by Cerenkov counting. As a negative control, the reverse transcription reaction followed by PCR was performed without addition of RNA. As positive controls, 10 ng human IRS-1 or insulin receptor cDNA was used as a PCR template. To determine the amount of IRS-1 PCR product derived from any contaminating genomic DNA, the reverse transcription and PCR reactions were also performed by omitting the reverse transcriptase.
Assay of PTPase Activity
The assay of PTPase activity was performed using a synthetic peptide derived from the autophosphorylated regulatory region of the insulin receptor P-subunit (residues 1154-l 165) as a phosphatase substrate (48). The peptide was labeled with insulin receptors that were solubilized from a membrane fraction of Chinese hamster ovary cells transfected with the cloned human insulin receptor and partially purified by wheat-germagglutinin-agarose chromatography.
Aliquots of the lectin column eluate were incubated with 1 PM insulin for 30 min at 4 C, after which 500 &i f3*P]ATP were added at a final concentration of 25 PM, followed by MnCI, to 5 mM and 1 mg of the 1154-l 165 oeotide in a volume of 350 ~1. After 16 h at 4 C. 1 ml of 5% (wt/vbl) trichloroacetic acid was added, and the 32P-labeled peptide in the supernatant was purified on AGl-X2 acetate resin followed by passage through a Cl8 
